Clinical Trial Update: Efficacy and Safety of 4-aminopyridine on Cognitive Performance and Motor Function of Patients With Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating 4-aminopyridine for cognitive performance and motor function in multiple sclerosis patients; study completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• 4-aminopyridine (4-aminopyridine)

Snippet

Sponsor: Coordinación de Investigación en Salud, Mexico | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2019-09-12